World's Best Scientists 2026 revealed!
Paolo Angeli

Paolo Angeli

D-Index & Metrics

Medicine

D-Index
102
Citations
43017
World Ranking
7597
National Ranking
254

Overview

Paolo Angeli is affiliated with the University of Padua in Italy and has a significant research presence in the field of medicine, with a particular focus on hepatology. Their work concentrates heavily on liver disease and transplantation, encompassing various topics related to liver disease diagnosis and treatment as well as drug-induced hepatotoxicity and protection.

Their research interests extend into several subfields, including hepatology, epidemiology, surgery, pharmacology, and pulmonary and respiratory medicine. This multidisciplinary focus reflects in the diverse range of topics covered across their publications, such as liver disease diagnosis and treatment, organ transplantation techniques and outcomes, hepatitis C virus research, and hepatocellular carcinoma treatment and prognosis.

Angeli has contributed a substantial number of publications to a core set of journals related to liver diseases and gastroenterology. Frequent publication venues include:

  • Journal of Hepatology
  • Digestive and Liver Disease
  • JHEP Reports
  • Hepatology
  • Gut

Some of the recent notable papers associated with or relevant to their research interests include:

  • The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology, 2020, Journal of Hepatology
  • The systemic inflammation hypothesis: Towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis, 2020, Journal of Hepatology
  • Albumin in decompensated cirrhosis: new concepts and perspectives, 2020, Gut
  • PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis, 2020, Journal of Hepatology
  • EASL Clinical Practice Guidelines on acute-on-chronic liver failure, 2023, Journal of Hepatology

Angeli's network of frequent co-authors underscores collaborative efforts in hepatology and related fields. Frequent collaborators include:

  • Salvatore Piano
  • Patrizia Burra
  • Vlad Ratziu
  • Paolo Caraceni
  • Stefan Zeuzem

The bulk of Angeli's scientific output and research activity centers around liver diseases, particularly those involving acute and chronic liver failure, inflammation in liver conditions, transplantation outcomes, and pharmacological protection against liver damage. Their extensive publication record in prominent specialized journals and collaboration with several researchers in related fields reflect a broad and detailed engagement with the medical study of hepatology and liver-related clinical challenges.

Best Publications

  • Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis

    Richard Moreau;Rajiv Jalan;Pere Gines;Marco Pavesi

  • EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis

    Paolo Angeli;Mauro Bernardi;Càndid Villanueva;Claire Francoz

  • Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites

    Paolo Angeli;Pere Ginès;Florence Wong;Mauro Bernardi

  • The management of ascites in cirrhosis: Report on the consensus conference of the international Ascites club

    Kevin P. Moore;Florence Wong;Pere Gines;Mauro Bernardi

  • Bacterial infections in cirrhosis: A position statement based on the EASL Special Conference 2013

    Rajiv Jalan;Javier Fernandez;Reiner Wiest;Bernd Schnabl

  • Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure

    Rajiv Jalan;Faouzi Saliba;Marco Pavesi;Alex Amoros

  • Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis

    A Gines;G Fernandez-Esparrach;A Monescillo;C Vila

  • Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure.

    Joan Clària;Rudolf E Stauber;Minneke J Coenraad;Richard Moreau

  • Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide.

    Paolo Angeli;Roberta Volpin;Giorgio Gerunda;Raffaella Craighero

  • Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosis

    Thierry Gustot;Javier Fernandez;Elisabet Garcia;Filippo Morando

  • Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study.

    M. Borzio;F. Salerno;L. Piantoni;M. Cazzaniga

  • Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis

    Mauro Bernardi;Richard Moreau;Richard Moreau;Paolo Angeli;Bernd Schnabl;Bernd Schnabl

  • Hyponatremia in cirrhosis: Results of a patient population survey.

    Paolo Angeli;Florence Wong;Hugh Watson;Pere Ginès

  • The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology.

    Jonel Trebicka;Javier Fernandez;Maria Papp;Paolo Caraceni

  • Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis

    Florence Suet Hing Wong;Mitra K Nadim;John A Kellum;Francesco Salerno

  • Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial.

    Paolo Caraceni;Oliviero Riggio;Paolo Angeli;Carlo Alessandria

  • Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features.

    Silvano Fasolato;Paolo Angeli;Lucia Dallagnese;Giulio Maresio

  • Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide

    Salvatore Piano;Virendra Singh;Paolo Caraceni;Rakhi Maiwall

  • Natural history of portal hypertensive gastropathy in patients with liver cirrhosis

    Massimo Primignani;Luca Carpinelli;Paoletta Preatoni;Giorgio Battaglia

  • Limitations of Serum Creatinine Level and Creatinine Clearance as Filtration Markers in Cirrhosis

    Lorenza Caregaro;Francesca Menon;Paolo Angeli;Piero Amodio

Frequent Co-Authors

Angelo Gatta
Angelo Gatta University of Padua
Pere Ginès
Pere Ginès University of Barcelona
Mauro Bernardi
Mauro Bernardi University of Bologna
Patrizia Burra
Patrizia Burra University of Padua
Vicente Arroyo
Vicente Arroyo University of Barcelona
Rajiv Jalan
Rajiv Jalan University College London
Jonel Trebicka
Jonel Trebicka University Hospital of Münster
Alexander L. Gerbes
Alexander L. Gerbes Ludwig-Maximilians-Universität München
François Durand
François Durand Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine opens doors to many connected fields and flexible study options. For those looking to enter nursing, there are lpn program no entrance exam options available, making it easier to get started without the stress of standardized testing. This pathway is ideal for those who want to quickly begin working in healthcare.

For students seeking to move into administrative roles, accelerated healthcare programs allow you to finish your education faster and start managing healthcare environments sooner.

Nurses aiming for advanced practice can explore rn to np programs, which offer streamlined routes from associate degrees to nurse practitioner credentials. These bridge programs help prepared nurses expand their duties and earning potential.

Beyond clinical roles, the demand for wellness experts is growing. Pursuing online degrees in nutrition can open opportunities in community health, counseling, and research, all through flexible, online learning platforms.

Best Scientists Citing Paolo Angeli

Trending Scientists

Recently Published Articles